Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-36,500
Closed -$2M 40
2020
Q4
$2M Buy
36,500
+6,500
+22% +$332K 1.39% 30
2020
Q3
$1.32M Sell
30,000
-23,000
-43% -$1.01M 1.72% 25
2020
Q2
$2.24M Sell
53,000
-131,312
-71% -$5.05M 2.7% 15
2020
Q1
$7.33M Sell
184,312
-74,021
-29% -$3.13M 6.63% 6
2019
Q4
$11.5M Buy
258,333
+10,784
+4% +$415K 6.54% 4
2019
Q3
$8.47M Buy
247,549
+163,549
+195% +$5.66M 6.12% 5
2019
Q2
$3.16M Buy
+84,000
New +$2.87M 4.36% 7

Other funds holding ACA

Harvey Partners's ACA Position: Q1 2021 in Review

Harvey Partners sold out of Arcosa (ACA) in Q1 2021, closing a stake of 36,500 shares — an estimated $2M sold.

Harvey Partners first reported a position in ACA in Q2 2019 and held it in 7 quarters. The position peaked at $11.5M in Q4 2019. 265 funds tracked by Wall St. Rank hold ACA as of Q1 2021.

  • Harvey Partners reported no remaining Arcosa position as of Q1 2021 after selling out during the quarter.
  • Harvey Partners sold 36,500 Arcosa shares in Q1 2021, an estimated $2M.
  • Harvey Partners first reported a position in Arcosa in Q2 2019 and held it in 7 quarters.
  • Harvey Partners's Arcosa position peaked at $11.5M in Q4 2019.
  • 265 funds tracked by Wall St. Rank held Arcosa as of Q1 2021.

Based on Harvey Partners's 13F filing for Q1 2021, filed 17 May 2021.